Fundz
Free weekly newsletter

Get the free weekly M&A digest

The new M&A deals, who’s behind them, and what they mean — delivered to your inbox every week. No credit card, unsubscribe anytime.

Weekly Digest

New M&A deals, summarized for you

Straight to Inbox

No login, no app to check — it comes to you

Deal Trends

See who's moving and how much in your market

No credit card required Weekly M&A digest

ABS Bio acquires Cureline to enhance services

PRIVATEJan 06, 20265 months ago

Acquiring Company

Analytical Biological Services

Acquired Company

Cureline

New CastleSouth San FranciscoBiotechnologyBiotechnologyHealth Care

Description

Analytical Biological Services, Inc. (ABS Bio) has acquired Cureline, Inc., a provider of specimen procurement and histology services. This acquisition expands ABS Bio's capabilities and geographic reach in the biospecimen market. The deal marks ABS Bio's first tuck-in acquisition under 3 Boomerang Capital's investment since June 2024.

Company Information

Company

Analytical Biological Services

Location

New Castle, Delaware, United States

About

Analytical Biological Services, Inc. (ABS Bio) is a leader in biospecimen sourcing, cell culture services, and biorepository solutions for the pharmaceutical and biotechnology industry. Founded in 1990, ABS Bio accelerates research and discovery by providing reliable procurement and quality control of biological products. The company focuses on building long-term client relationships with major pharmaceutical firms.

Related People

Choose your plan to reveal verified contacts

Predictive Intelligence
Strategic

ML-powered predictions for Analytical Biological Services's next move

Learn about Strategic plan

M&A Insights

Based on deal data
Integration timeline
70% of M&A integrations take 12-24 months to complete
Tech stack consolidation
83% of merged companies consolidate technology vendors within first year
Post-acquisition investment
Companies increase IT spending by 23% on average after acquisitions
Success factor
M&A deals with strong technology integration plans are 2.5x more likely to succeed

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals — including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications — based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.